Tiziana Life Sciences Ltd
TLSANASDAQHealthcare● Active
$1.22
$-0.00(-0.41%)
Market Cap$72202592
P/E Ratio—
52W High$2.6
52W Low$1.08
Tiziana Life Sciences Ltd (TLSA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TLSA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 1, 2026EPS Actual
-$0.22
Est. -$0.09 · -143.0%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 1, 2026
After Market Close
▼ Miss EPS
TLSA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2026 | Oct 7, 2026 | -$0.08 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 1, 2026 | -$0.09 | -$0.22 | -143.0% | — | — | — |
| ◌ Q4 FY2025 | Oct 13, 2025 | — | — | — | — | — | — |
| ▼ Q3 FY2025 | Jul 8, 2025 | -$0.07 | -$0.10 | -35.4% | — | — | — |
| — Q2 FY2025 | Jun 23, 2025 | — | -$0.13 | — | — | — | — |
| — Q2 FY2025 | May 20, 2025 | — | -$0.06 | — | — | — | — |
| ◌ Q4 FY2024 | Oct 18, 2024 | — | — | — | — | — | — |
| — Q2 FY2024 | Jun 30, 2024 | — | -$0.18 | — | — | — | — |
Q4 FY2026
Oct 7, 2026
EPS Actual
—
EPS Est.
-$0.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 1, 2026Miss
EPS Actual
-$0.22
EPS Est.
-$0.09
EPS Surpr.
-143.0%
Revenue
—
Q4 FY2025
Oct 13, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 8, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.07
EPS Surpr.
-35.4%
Revenue
—
Q2 FY2025
Jun 23, 2025
EPS Actual
-$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 20, 2025
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Oct 18, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 30, 2024
EPS Actual
-$0.18
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 1, 2026 | -143.0% | $1.28 | $1.34 | +4.69% |
| ▼ Q3 FY2025 | Jul 8, 2025 | -35.4% | $1.53 | $1.49 | -2.61% |
| — Q2 FY2025 | Jun 23, 2025 | — | $1.56 | $1.55 | -0.64% |
| — Q2 FY2025 | May 20, 2025 | — | $1.48 | $1.50 | +1.35% |
| — Q2 FY2024 | Jun 30, 2024 | — | $0.92 | $0.89 | -3.63% |
| — Q2 FY2024 | May 11, 2024 | — | $0.62 | $0.61 | -1.78% |
| — Q4 FY2023 | Dec 26, 2023 | — | No price data | $0.60 | — |
Q2 FY2026+4.69%
Report Date
May 1, 2026
EPS Beat/Miss
-143.0%
Price Before
$1.28
Price After
$1.34
Q3 FY2025-2.61%
Report Date
Jul 8, 2025
EPS Beat/Miss
-35.4%
Price Before
$1.53
Price After
$1.49
Q2 FY2025-0.64%
Report Date
Jun 23, 2025
EPS Beat/Miss
—
Price Before
$1.56
Price After
$1.55
Q2 FY2025+1.35%
Report Date
May 20, 2025
EPS Beat/Miss
—
Price Before
$1.48
Price After
$1.50
Q2 FY2024-3.63%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$0.92
Price After
$0.89
Q2 FY2024-1.78%
Report Date
May 11, 2024
EPS Beat/Miss
—
Price Before
$0.62
Price After
$0.61
Q4 FY2023—
Report Date
Dec 26, 2023
EPS Beat/Miss
—
Price Before
—
Price After
$0.60
Avg Miss Reaction+1.04%
Beat Rate0 / 7 quarters
Largest Move+4.69% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TLSA ends December
Tiziana Life Sciences Ltd (TLSA) most recently reported earnings on May 1, 2026 for Q2 FY2026, posting EPS of $-0.22 — missing the analyst consensus of $-0.09 by -143.0%. The next TLSA earnings date is expected around September 1, 2026.
Each quarter, investors track TLSA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TLSA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TLSA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TLSA earnings · 5 questionsTiziana Life Sciences Ltd's next earnings report is expected around September 1, 2026. TLSA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TLSA historically reports after market close (AMC).
TLSA earnings datewhen is TLSA earningsTLSA next earnings datewhen does TLSA report earningsTLSA earnings calendar
▸ Source: FMP · Tiziana Life Sciences Ltd SEC filings · US GAAP · Tiziana Life Sciences Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026